Alejandro “Alex” Arroliga, MD

Alejandro “Alex” Arroliga, MD, has been named chief clinical innovation officer of Baylor Scott & White Health, effective June 20, 2022. In this newly created role, Dr. Arroliga will partner with leaders across the system to identify, evaluate and pursue clinical innovations designed to improve patient experiences.